Remove Capital Remove Framework Remove IP Remove Study
article thumbnail

Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan

socalTECH

The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.

article thumbnail

Interview with Michael Witz, Mob Science

socalTECH

We have one, major original IP game in development, and a couple of weeks ago we announced a publishing deal with Zynga to publish our new game on Facebook and Zynga's own platform. We started working on the new IP, and that's the game we announced the deal with Zynga on. We spoke with CEO Michael Witz about the company.

IP 217